Source:http://linkedlifedata.com/resource/pubmed/id/19795175
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-3-24
|
pubmed:abstractText |
Catechol-O-methyl transferase (COMT) is a pivotal regulator of brain dopamine function with a region-specific role. COMT is important in dopamine elimination in the prefrontal cortex, whereas dopamine reuptake is the main mechanism for synaptic removal of dopamine in the striatum. We studied whether the functional COMT gene polymorphism (Val158Met) associates with altered dopamine D2 receptor binding characteristics in vivo hypothesizing an effect in the cortex but not in the striatum.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1860-2002
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
192-7
|
pubmed:meshHeading |
pubmed-meshheading:19795175-Adult,
pubmed-meshheading:19795175-Amino Acid Substitution,
pubmed-meshheading:19795175-Catechol O-Methyltransferase,
pubmed-meshheading:19795175-Cerebral Cortex,
pubmed-meshheading:19795175-Corpus Striatum,
pubmed-meshheading:19795175-Demography,
pubmed-meshheading:19795175-Genotype,
pubmed-meshheading:19795175-Humans,
pubmed-meshheading:19795175-Ligands,
pubmed-meshheading:19795175-Receptors, Dopamine D2
|
pubmed:year |
2010
|
pubmed:articleTitle |
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo.
|
pubmed:affiliation |
Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|